《新股消息》誉燊丰控股(02132.HK)每股下限定价0.325元 一手中签率10%
本港建造工程承建商誉燊丰控股(02132.HK)公布招股结果,拟发行4亿股,公开发售录超购58.05倍,重经新分配後,公开发售股数增至40%。每手8,000股,一手中签率为10%。该股将於明日(10月20日)上市。独家保荐为富比资本,联席账簿管理人为新城晋峰及德林证券。
誉燊丰控股表示,每股发售价定於0.325元,为下限定价(招股价介乎0.325元至0.34元),公司预计集资净额为5,870万元,其中40.1%预期将用於为三个现有主承建商项目提供资金,31%预期将用於购置机器及设备以升级并扩大机队,及促进现有营运,19.7%将用於组建新项目管理团队并增强总部的人力,4.1%用於升级企业信息系统,3.5%将用於一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.